Please use this identifier to cite or link to this item:
http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hamoda, T. | - |
dc.contributor.author | Shah, R. | - |
dc.contributor.author | Mostafa, T. | - |
dc.contributor.author | Germar-Michael, P. | - |
dc.contributor.author | Atmoko, W. | - |
dc.contributor.author | Balagobi, B. | - |
dc.date.accessioned | 2025-07-24T06:15:13Z | - |
dc.date.available | 2025-07-24T06:15:13Z | - |
dc.date.issued | 2025 | - |
dc.identifier.uri | http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/11432 | - |
dc.description.abstract | Purpose: Non-obstructive azoospermia (NOA), defined as the absence of sperm in the ejaculate due to testicular failure, is observed in 5% to 15% of infertile men and accounts for two-thirds of azoospermia cases. The management of NOA is marked by significant controversy and global variation in diagnostic and therapeutic approaches, highlighting the crucial need for well-designed and standardized clinical practice guidelines. We present comprehensive graded clinical practice recommendations and statements for diagnosing and treating NOA, aiming to establish standardized strategies that can glob- ally help guide practitioners in their practice. Materials and Methods: A comprehensive literature review was conducted to gather evidence on the epidemiological, di- agnostic, and therapeutic aspects of NOA. The Global Andrology Forum (GAF) recommendations were developed through the collaboration of a global panel of experts using the Delphi method and surveys to achieve consensus. Statements were graded according to the Oxford Centre for Evidence-Based Medicine “GRADE” classification as either “Strong” or “Weak.” Statements receiving at least 80% expert consensus were graded as “Strong,” while others were categorized as “Weak.” Results: The GAF has formulated a total of 49 recommendations and statements on the diagnosis and treatment of NOA, in- cluding 21 for diagnosis and 28 for treatment. The recommendations and statements were evaluated and graded by a panel of 48 GAF experts from 25 countries worldwide. The majority of experts (60.5%) had more than 10 years of clinical experi- ence in managing NOA. Conclusions: The GAF guidelines address discrepancies in NOA management across diverse clinical settings and provide comprehensive graded recommendations to guide clinicians in its diagnosis and treatment. Developed and graded by a large worldwide panel of experts, the current guidelines present simplified, high-standard strategies that can be seamlessly inte- grated into the daily global practice, offering practitioners a clear framework for managing NOA. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Korean Society for Sexual Medicine and Andrology | en_US |
dc.subject | Azoospermia | en_US |
dc.subject | Guideline | en_US |
dc.subject | Infertility | en_US |
dc.subject | Pregnancy | en_US |
dc.subject | Semen | en_US |
dc.subject | Sperm retrieval | en_US |
dc.title | Global Andrology Forum (GAF) Clinical Guidelines on the Management of Non-obstructive Azoospermia: Bridging the Gap between Controversy and Consensus | en_US |
dc.type | Article | en_US |
Appears in Collections: | Surgery |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Global Andrology Forum (GAF) Clinical.pdf | 873.71 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.